

Icosavax, a developer of vaccines against infection diseases, has raised $100 million in Series B Financing. RA Capital Management led the round.
Source: Press Release
Icosavax, a developer of vaccines against infection diseases, has raised $100 million in Series B Financing.
Icosavax, a developer of vaccines against infection diseases, has raised $100 million in Series B Financing. RA Capital Management led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination